Connecting oncology professionals with relevant clinical trials

Selected clinical trial

MESE: Phase II study of sertraline plus cisplatin or carboplatin and pemetrexed for unresectable epithelioid pleural mesothelioma

Sponsor: Centro Di Riferimento Oncologico Di Aviano

Phase: 2

Disease: Unresectable epithelioid malignant pleural mesothelioma

EU trial number: 2026-526791-23-00

Population: Adults ≥18 years with previously untreated histologically confirmed unresectable advanced epithelioid malignant pleural mesothelioma (stage III–IV), ECOG 0–1, adequate organ function and suitability for first-line platinum-pemetrexed chemotherapy.

Register Investigator Interest

Interested in offering this trial to suitable patients?